Structure and immunogenicity of the rough-type lipopolysaccharide from the periodontal pathogen Tannerella forsythia

Clinical and Vaccine Immunology

Volumn 20, Issue 6, 2013, Pages 920-930

  Posch, Gerald ^a   Andrukhov, Oleh ^b   Vinogradov, Evgeny ^c   Lindner, Buko ^d   Messner, Paul ^c   Holst, Otto ^d   Schäffer, Christina ^a  

^a UNIVERSITY OF NATURAL RESOURCES AND LIFE SCIENCES   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^d RESEARCH CENTER BORSTEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; GALACTOSE; GLUCOSAMINE; INTERLEUKIN 1; INTERLEUKIN 6; MANNOSE; PHOSPHATE; PHOSPHOETHANOLAMINE; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; LIPOPOLYSACCHARIDE;

ARTICLE; CARBOHYDRATE ANALYSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; FETAL CALF SERUM; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; IMMUNOGENICITY; IMMUNOSTIMULATION; MACROPHAGE ACTIVATION; NONHUMAN; PERIODONTIUM; PRIORITY JOURNAL; STRUCTURE ANALYSIS; SURFACE PROPERTY; TANNERELLA FORSYTHENSIS; BACTEROIDETES; CELL LINE; CHEMISTRY; DRUG EFFECTS; IMMUNOLOGY; ISOLATION AND PURIFICATION; MACROPHAGE; MASS SPECTROMETRY; MICROBIOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PERIODONTITIS; SECRETION (PROCESS);

BACTEROIDETES; CELL LINE; CYTOKINES; HUMANS; LIPOPOLYSACCHARIDES; MACROPHAGES; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; PERIODONTITIS;

EID: 84891379992     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00139-13     Document Type: Article

References (57)

1. Tanner ACR, Izard J. 2006. Tannerella forsythia, a periodontal pathogen entering the genomic era. Periodontol. 2000 42:88-113. (Pubitemid 44286049)
2. Holt SC, Ebersole JL. 2005. Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia: the "red complex," a prototype polybacterial pathogenic consortium in periodontitis. Periodontol. 2000 38:72-122. (Pubitemid 43034324)
3. Haffajee AD, Socransky SS. 1994. Microbial etiological agents of destructive periodontal diseases. Periodontol. 2000 5:78-111.
4. Li X, Kolltveit KM, Tronstad L, Olsen I. 2000. Systemic diseases caused by oral infection. Clin. Microbiol. Rev. 13:547-558.
5. Leishman SJ, Do HL, Ford PJ. 2010. Cardiovascular disease and the role of oral bacteria. J. Oral Microbiol. 2:5781-5793.
6. Ebersole JL, Taubman MA. 1994. The protective nature of host responses in periodontal diseases. Periodontol. 2000 5:112-141.
7. Madianos PN, Bobetsis YA, Kinane DF. 2005. Generation of inflammatory stimuli: how bacteria set up inflammatory responses in the gingiva. J. Clin. Periodontol. 32:57-71. (Pubitemid 41391057)
8. Sharma A. 2010. Virulence mechanisms of Tannerella forsythia. Periodontol. 2000 54:106-116.
9. Sharma A, Sojar HT, Glurich I, Honma K, Kuramitsu HK, Genco RJ. 1998. Cloning, expression, and sequencing of a cell surface antigen containing a leucine-rich repeat motif from Bacteroides forsythus ATCC 43037. Infect. Immun. 66:5703-5710. (Pubitemid 28531825)
10. Murakami Y, Higuchi N, Nakamura H, Yoshimura F, Oppenheim FG. 2002. Bacteroides forsythus hemagglutinin is inhibited by N-acetylneuraminyllactose. Oral Microbiol. Immunol. 17:125-128.
11. Hasebe A, Yoshimura A, Into T, Kataoka H, Hara Y, Shibata K-I. 2004. Biological activities of Bacteroides forsythus lipoproteins and their possible pathological roles in periodontal disease. Infect. Immun. 72:1318-1325. (Pubitemid 38263751)
12. Grenier D. 1995. Characterization of the trypsin-like activity of Bacteroides forsythus. Microbiology 141:921-926.
13. Saito T, Ishihara K, Kato T, Okuda K. 1997. Cloning, expression, and sequencing of a protease gene from Bacteroides forsythus ATCC 43037 in Escherichia coli. Infect. Immun. 65:4888-4891. (Pubitemid 27463275)
14. Hughes CV, Malki G, Loo CY, Tanner ACR, Ganeshkumar N. 2003. Cloning and expression of α-D-glucosidase and N-acetyl-β-glucosaminidase from the periodontal pathogen, Tannerella forsythensis (Bacteroides forsythus). Oral Microbiol. Immunol. 18:309-312. (Pubitemid 37087263)
15. Thompson H, Homer KA, Rao S, Booth V, Hosie AHF. 2009. An orthologue of Bacteroides fragilis NanH is the principal sialidase in Tannerella forsythia. J. Bacteriol. 191:3623-3628.
16. Sabet M, Lee S-W, Nauman RK, Sims T, Um H-S. 2003. The surface (S-)layer is a virulence factor of Bacteroides forsythus. Microbiology 149:3617-3627. (Pubitemid 38016688)
17. Sakakibara J, Nagano K, Murakami Y, Higuchi N, Shimozato K, Yoshimura F. 2007. Loss of adherence ability to human gingival epithelial cells in S-layer protein-deficient mutants of Tannerella forsythensis. Microbiology 153:866-876. (Pubitemid 46444384)
18. Sekot G, Posch G, Messner P, Matejka M, Rausch-Fan X, Andrukhov O, Schäffer C. 2011. Potential of the Tannerella forsythia S-layer to delay the immune response. J. Dent. Res. 90:109-114.
19. Posch G, Pabst M, Brecker L, Altmann F, Messner P, Schäffer C. 2011. Characterization and scope of S-layer protein O-glycosylation in Tannerella forsythia. J. Biol. Chem. 286:38714-38724.
20. Settem RP, Honma K, Nakajima T, Phansopa C, Roy S, Stafford GP, Sharma A. 2013. A bacterial glycan core linked to surface (S)-layer proteins modulates host immunity through Th17 suppression. Mucosal Immunol. 6:415-426.
21. Erridge C, Bennett-Guerrero E, Poxton IR. 2002. Structure and function of lipopolysaccharides. Microbes Infect. 4:837-851. (Pubitemid 35247447)
22. Bodet C, Grenier D. 2010. Synergistic effects of lipopolysaccharides from periodontopathic bacteria on pro-inflammatory cytokine production in an ex vivo whole blood model. Mol. Oral Microbiol. 25:102-111.
23. Raetz CRH, Whitfield C. 2002. Lipopolysaccharide endotoxins. Annu. Rev. Biochem. 71:635-700. (Pubitemid 34800232)
24. Moran AP, Lindner B, Walsh EJ. 1997. Structural characterization of the lipid A component of Helicobacter pylori rough- and smooth-form lipopolysaccharides. J. Bacteriol. 179:6453-6463. (Pubitemid 27443930)
25. Janusch H, Brecker L, Lindner B, Alexander C, Gronow S, Heine H, Ulmer AJ, Rietschel ET, Zähringer U. 2002. Structural and biological characterization of highly purified hepta-acyl lipid A present in the lipopolysaccharide of the Salmonella enterica sv. Minnesota Re deep rough mutant strain R595. J. Endotoxin Res. 8:343-356. (Pubitemid 35460669)
26. Galanos C, Lüderitz O, Westphal O. 1969. A new method for the extraction of R lipopolysaccharides. Eur. J. Biochem. 9:245-249.
27. Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
28. Hitchcock PJ, Brown TM. 1983. Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels. J. Bacteriol. 154:269-277. (Pubitemid 13115445)
29. Sawardeker JS, Sloneker JH, Jeanes A. 1965. Quantitative determination of monosaccharides as their alditol acetates by gas liquid chromatography. Anal. Chem. 37:1602-1604.
30. Gerwig GJ, Kamerling JP, Vliegenthart JFG. 1979. Determination of the absolute configuration of monosaccharides in complex carbohydrates by capillary g.l.c. Carbohydr. Res. 77:1-7.
31. Oertelt C, Lindner B, Skurnik M, Holst O. 2001. Isolation and structural characterization of an R-form lipopolysaccharide from Yersinia enterocolitica serotype O:8. Eur. J. Biochem. 268:554-564. (Pubitemid 32862613)
32. Ciucanu I, Kerek F. 1984. A simple and rapid method for the permethylation of carbohydrates. Carbohydr. Res. 131:209-217.
33. Holst O. 2000. Deacylation of lipopolysaccharides and isolation of oligosaccharide phosphates, p 345-353. In Holst O (ed), Bacterial toxins: methods and protocols, vol 145. Humana Press, New York, NY.
34. Bertl K, An N, Bruckmann C, Dard M, Andrukhov O, Matejka M, Rausch-Fan X. 2009. Effects of enamel matrix derivative on proliferation/viability, migration, and expression of angiogenic factor and adhesion molecules in endothelial cells in vitro. J. Periodontol. 80:1622-1630.
35. Kondakova A, Lindner B. 2005. Structural characterization of complex bacterial glycolipids by Fourier transform mass spectrometry. Eur. J. Mass Spectrom. 11:535-546. (Pubitemid 41796542)
36. Holst O, Broer W, Thomas-Oates JE, Mamat U, Brade H. 1993. Structural analysis of two oligosaccharide bisphosphates isolated from the lipopolysaccharide of a recombinant strain of Escherichia coli F515 (Re chemotype) expressing the genus-specific epitope of Chlamydia lipopolysaccharide. Eur. J. Biochem. 214:703-710. (Pubitemid 23188145)
37. Holst O, Bock K, Brade L, Brade H. 1995. The structures of oligosaccharide bisphosphates isolated from the lipopolysaccharide of a recombinant Escherichia coli strain expressing the gene gseA [3-deoxy-D-manno-octulopyranosonic acid (Kdo) transferase] of Chlamydia psittaci 6BC. Eur. J. Biochem. 229:194-200.
38. Velasco J, Moll H, Knirel YA, Sinnwell V, Moriyón I, Zähringer U. 1998. Structural studies on the lipopolysaccharide from a rough strain of Ochrobactrum anthropi containing a 2,3-diamino-2,3-dideoxy-D- glucose disaccharide lipid A backbone. Carbohydr. Res. 306:283-290. (Pubitemid 28304996)
39. Zähringer U, Knirel YA, Lindner B, Helbig JH, Sonesson A, Marre R, Rietschel ET. 1995. The lipopolysaccharide of Legionella pneumophila serogroup 1 (strain Philadelphia 1): chemical structure and biological significance. Prog. Clin. Biol. Res. 392:113-139.
40. Forsberg LS, Carlson RW. 1998. The structures of the lipopolysaccharides from Rhizobium etli strains CE358 and CE359: the complete structure of the core region of R. etli lipopolysaccharides. J. Biol. Chem. 273:2747-2757. (Pubitemid 28133920)
41. Vinogradov EV, Duus JØ, Brade H, Holst O. 2002. The structure of the carbohydrate backbone of the lipopolysaccharide from Acinetobacter baumannii strain ATCC 19606. Eur. J. Biochem. 269:422-430. (Pubitemid 34130142)
42. Avci FY, Kasper DL. 2010. How bacterial carbohydrates influence the adaptive immune system. Annu. Rev. Immunol. 28:107-130.
43. Müller-Loennies S, Holst O, Lindner B, Brade H. 1999. Isolation and structural analysis of phosphorylated oligosaccharides obtained from Escherichia coli J-5 lipopolysaccharide. Eur. J. Biochem. 260:235-249. (Pubitemid 29095715)
44. Zähringer U, Lindner B, Rietschel ET. 1999. Chemical structure of lipid A: recent advances in structural analysis of biologically active molecules, p 93-114. In Brade H, Opal S, Vogel S, Morrison D (ed), Endotoxin in health and disease. Marcel Dekker, New York, NY.
45. Holst O, Molinaro A. 2009. Core region and lipid A components of lipopolysaccharides, p 29-55. In Moran AP, Holst O, Brennan PJ, von Itzstein M (ed), Microbial glycobiology. Structures, relevance and applications. Elsevier, Amsterdam, The Netherlands.
46. Martin M, Katz J, Vogel SN, Michalek SM. 2001. Differential induction of endotoxin tolerance by lipopolysaccharides derived from Porphyromonas gingivalis and Escherichia coli. J. Immunol. 167:5278-5285. (Pubitemid 33009766)
47. Ogawa T, Uchida H, Amino K. 1994. Immunobiological activities of chemically defined lipid A from lipopolysaccharides of Porphyromonas gingivalis. Microbiology 140:1209-1216. (Pubitemid 24157873)
48. Bodet C, Chandad F, Grenier D. 2006. Inflammatory responses of a macrophage/epithelial cell co-culture model to mono and mixed infections with Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia. Microbes Infect. 8:27-35. (Pubitemid 43139289)
49. Ogawa T. 1993. Chemical structure of lipid A from Porphyromonas (Bacteroides) gingivalis lipopolysaccharide. FEBS Lett. 332:197-201. (Pubitemid 23295927)
50. Darveau RP, Pham T-T, Lemley TK, Reife RA, Bainbridge BW, Coats SR, Howald WN, Way SS, Hajjar AM. 2004. Porphyromonas gingivalis lipopolysaccharide contains multiple lipid A species that functionally interact with both Toll-like receptors 2 and 4. Infect. Immun. 72:5041-5051. (Pubitemid 39223388)
51. Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y, Takeda K, Akira S. 1999. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 162:3749-3752. (Pubitemid 29314747)
52. Raetz CRH, Ulevitch RJ, Wright SD, Sibley CH, Ding A, Nathan CF. 1991. Gram-negative endotoxin: an extraordinary lipid with profound effects on eukaryotic signal transduction. FASEB J. 5:2652-2660. (Pubitemid 21905816)
53. Miyake K. 2004. Endotoxin recognition molecules, Toll-like receptor 4-MD-2. Semin. Immunol. 16:11-16. (Pubitemid 38147428)
54. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. 1990. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249:1431-1433.
55. Shimazu R, Akashi S, Ogata H, Nagai Y, Fukudome K, Miyake K, Kimoto M. 1999. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J. Exp. Med. 189:1777-1782. (Pubitemid 29272694)
56. Fitzgerald KA, Rowe DC, Golenbock DT. 2004. Endotoxin recognition and signal transduction by the TLR4/MD2-complex. Microbes Infect. 6:1361-1367. (Pubitemid 41110578)
57. Kocgozlu L, Elkaim R, Tenenbaum H, Werner S. 2009. Variable cell responses to P. gingivalis lipopolysaccharide. J. Dent. Res. 88:741-745.